基本信息
views: 199
Career Trajectory
Bio
His research interests include non-communicable diseases such as cardiovascular disease, and he currently chairs WHO guidelines on self-care and cardiovascular disease risk. He is also interested in the treatment of communicable diseases in primary care.
Professor Heneghan also investigates the evidence base for publication bias and drug and device regulation, and he is an international expert, advising governments, on the regulatory and evidence requirements for devices and drugs as well as evidence-based projects in the public interest. He is also a founder of the AllTrials campaign.
Professor Heneghan also investigates the evidence base for publication bias and drug and device regulation, and he is an international expert, advising governments, on the regulatory and evidence requirements for devices and drugs as well as evidence-based projects in the public interest. He is also a founder of the AllTrials campaign.
Research Interests
Papers共 627 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Carl Heneghan,IGHO ONAKPOYA,Jon Brassey, James P Shepperd,Apostolos Tsiachristas, Kamaldeep Bhui,Rafael Perera,Derrick Bennett
medrxiv(2024)
medrxiv(2024)
crossref(2024)
Ranin Soliman,Nancy Bolous,Carl Heneghan,Jason Oke, Anne -Marie Boylan,Wael Eweida,Sherif Abouelnaga,Alaa Elhaddad
medrxiv(2024)
The British journal of general practice : the journal of the Royal College of General Practitionersno. 743 (2024): e393-e400
The British journal of general practice : the journal of the Royal College of General Practitioners (2024)
ARCHIVES OF DISEASE IN CHILDHOODno. 1 (2024): 30-36
Load More
Author Statistics
#Papers: 628
#Citation: 22501
H-Index: 75
G-Index: 135
Sociability: 8
Diversity: 0
Activity: 5
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn